Foralumab
Tiziana Life sciences
['congrat']
congratulations and $tanuja chitnis on your presentation today: nasal anti-cd3 monoclonal antibody (foralumab) reduces pet microglial activation and blood inflammatory biomarkers in two patients with non-active spms #multiplesclerosis #ectrims2022
Developing innovative drugs for the treatment of Crohn's Disease, COVID-19, Progressive Multiple Sclerosis (pro-MS) and Hepatocellular Carcinoma (HCC)